The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Offer, which generated strong interest from domestic retail investors, saw a total of 130,617 valid applications for 4,705,800,290 Ordinary Shares.
Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO) is pleased to announce the opening of the first clinical site for its lead asset, HG-CT-1, targeting relapsed ...
First Capital Treasuries PLC, a subsidiary of First Capital Holdings PLC, is pleased to announce the appointment of Channa de Silva as an Independent Non-Executive Director to the Company’s Board of ...
Published first on TheFly – the ult Autolus Therapeutics ( NASDAQ:AUTL ) Third Quarter 2024 Results Key Financial Results Net loss: US$82.1m (loss widened... Autolus Therapeutics PLC (AUTL ...
LONDON, UK / ACCESSWIRE / December 30, 2024 / Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO) is pleased to announce the opening of the first clinical site ...